Table 1 Number of samples and demographics of samples included in the study

From: Comprehensive analysis of normal adjacent to tumor transcriptomes

GTEx

TCGA

# of samples

Sex (% of females)

Age (mean ± SD)

  

H (healthy normal)

A (NAT)

T (tumor)

H

A

T

H

A

T

Lung

LUAD

374

59

541

34.2

56.1

53.1

52.1 ± 12.0

66.0 ± 11.0

65.9 ± 9.8

Colon

COAD

376

41

483

40.0

53.8

48.0

50.4 ± 12.6

70.7 ± 13.5

67.6 ± 13.1

Breast

BRCA

92

113

1119

100

100

100

51 ± 11.5

58.0 ± 14.4

59.1 ± 13.1

Uterus

UCEC

90

35

554

100

100

100

47.5 ± 13.4

59.9 ± 12.1

64.4 ± 11.1

Liver

LIHC

135

50

374

32.6

42.9

32.5

52.7 ± 11.3

61.3 ± 16.2

59.8 ± 13.4

Bladder

BLCA

11

19

414

46.2

47.4

26.4

42.5 ± 14.1

70.4 ± 11.3

68.6 ± 10.6

Prostate

PRAD

119

52

502

0.0

0.0

0.0

49.0 ± 13.6

60.9 ± 7.1

61.3 ± 6.8

Thyroid

THCA

361

59

513

36.5

70.7

72.9

52.0 ± 11.9

46.2 ± 17.2

47.8 ± 15.8

  1. H healthy normal from GTEx; A normal adjacent tumor (NAT) samples from TCGA; T tumor samples from TCGA